No Data
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT)
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
103677010 : noted
103425615 : good
山芭佬 :
105489590 : k